fbpx
QQQ
+ 3.21
341.15
+ 0.93%
DIA
+ 0.69
338.09
+ 0.2%
SPY
+ 2.27
418.59
+ 0.54%
TLT
+ 0.35
142.94
+ 0.24%
GLD
-0.70
167.65
-0.42%

Why Edesa Biotech Is Trading Higher Today

March 22, 2021 10:08 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Edesa Biotech's Stock Price And Volume Action

Edesa Biotech (NASDAQ:EDSA) is currently up 5.91% to a price of $5.91. Monday the stock has been traded at a volume of 656.23 thousand, about 183.14% of its recent 30-day volume average of 358.32 thousand.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Edesa Biotech shares are trading higher after the company announced it received FDA and Health Canada approval to add to its sub-study for its Phase 2/3 of its EB05 as potential rescue therapy for critically Covid-19.

Perspective On Recent Price Action

The stock's 50-day moving average was $5.92 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $19.1 and fallen to a low of $1.6.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Posted-In:

Movers Trading Ideas

Related Articles

12 Health Care Stocks Moving In Tuesday's Intraday Session

  read more

12 Health Care Stocks Moving In Monday's Pre-Market Session

  read more

72 Biggest Movers From Friday

Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares climbed 48% to close at $5.58 on Friday. Lixte Biotech recently said it will present its anti-cancer therapy enhancer at HC Wainwright Global Life Sciences Conference being held March 9-10, 2021. read more

48 Stocks Moving In Friday's Mid-Day Session

Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares jumped 52.8% to $5.76. Lixte Biotech recently said it will present its anti-cancer therapy enhancer at HC Wainwright Global Life Sciences Conference being held March 9-10, 2021. read more